164 related articles for article (PubMed ID: 38704409)
1. A multicenter proof-of-concept study on deep learning-based intraoperative discrimination of primary central nervous system lymphoma.
Zhang X; Zhao Z; Wang R; Chen H; Zheng X; Liu L; Lan L; Li P; Wu S; Cao Q; Luo R; Hu W; Lyu S; Zhang Z; Xie D; Ye Y; Wang Y; Cai M
Nat Commun; 2024 May; 15(1):3768. PubMed ID: 38704409
[TBL] [Abstract][Full Text] [Related]
2. Differentiation of primary central nervous system lymphoma from high-grade glioma and brain metastasis using arterial spin labeling and dynamic contrast-enhanced magnetic resonance imaging.
Xi YB; Kang XW; Wang N; Liu TT; Zhu YQ; Cheng G; Wang K; Li C; Guo F; Yin H
Eur J Radiol; 2019 Mar; 112():59-64. PubMed ID: 30777220
[TBL] [Abstract][Full Text] [Related]
3. Intraoperative rapid diagnosis of primary central nervous system lymphomas: advantages and pitfalls.
Sugita Y; Terasaki M; Nakashima S; Ohshima K; Morioka M; Abe H
Neuropathology; 2014 Oct; 34(5):438-45. PubMed ID: 24750231
[TBL] [Abstract][Full Text] [Related]
4. Hemorrhagic Attitude in Frameless and Frame-Based Stereotactic Biopsy for Deep-Seated Primary Central Nervous System Lymphomas in Immunocompetent Patients: A Multicentric Analysis of the Last Twenty Years.
Callovini GM; Sherkat S; Sperduti I; Crispo F; Raus L; Gazzeri R; Telera S
World Neurosurg; 2021 May; 149():e1017-e1025. PubMed ID: 33476784
[TBL] [Abstract][Full Text] [Related]
5. Intraoperative Flow Cytometry Enables the Differentiation of Primary Central Nervous System Lymphoma from Glioblastoma.
Koriyama S; Nitta M; Shioyama T; Komori T; Maruyama T; Kawamata T; Muragaki Y
World Neurosurg; 2018 Apr; 112():e261-e268. PubMed ID: 29330078
[TBL] [Abstract][Full Text] [Related]
6. Machine learning-based pathomics signature of histology slides as a novel prognostic indicator in primary central nervous system lymphoma.
Duan L; He Y; Guo W; Du Y; Yin S; Yang S; Dong G; Li W; Chen F
J Neurooncol; 2024 Jun; 168(2):283-298. PubMed ID: 38557926
[TBL] [Abstract][Full Text] [Related]
7. Presence of apoptosis distinguishes primary central nervous system lymphoma from glioblastoma during intraoperative consultation.
Cha YJ; Choi J; Kim SH
Clin Neuropathol; 2018; 37(3):105-111. PubMed ID: 29336777
[TBL] [Abstract][Full Text] [Related]
8. Neurocognitive features distinguishing primary central nervous system lymphoma from other possible causes of rapidly progressive dementia.
Deutsch MB; Mendez MF
Cogn Behav Neurol; 2015 Mar; 28(1):1-10. PubMed ID: 25812125
[TBL] [Abstract][Full Text] [Related]
9. Differentiating primary central nervous system lymphoma from glioma in humans using localised proton magnetic resonance spectroscopy.
Harting I; Hartmann M; Jost G; Sommer C; Ahmadi R; Heiland S; Sartor K
Neurosci Lett; 2003 May; 342(3):163-6. PubMed ID: 12757890
[TBL] [Abstract][Full Text] [Related]
10. The basics of intraoperative diagnosis in neuropathology.
Lee HS; Tihan T
Surg Pathol Clin; 2015 Mar; 8(1):27-47. PubMed ID: 25783820
[TBL] [Abstract][Full Text] [Related]
11. (1)H-MRS is useful to reinforce the suspicion of primary central nervous system lymphoma prior to surgery.
Mora P; Majós C; Castañer S; Sánchez JJ; Gabarrós A; Muntané A; Aguilera C; Arús C
Eur Radiol; 2014 Nov; 24(11):2895-905. PubMed ID: 25027839
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of Enhancing Glioma and Primary Central Nervous System Lymphoma by Texture-Based Machine Learning.
Alcaide-Leon P; Dufort P; Geraldo AF; Alshafai L; Maralani PJ; Spears J; Bharatha A
AJNR Am J Neuroradiol; 2017 Jun; 38(6):1145-1150. PubMed ID: 28450433
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of multimodal magnetic resonance in the differential diagnosis of acquired immune deficiency syndrome related primary central nervous system lymphoma and infection.
Li J; Xue M; Yan S; Guan C; Xie R; Chen B
BMC Infect Dis; 2021 Feb; 21(1):165. PubMed ID: 33568094
[TBL] [Abstract][Full Text] [Related]
14. Glioblastoma and primary central nervous system lymphoma: Preoperative differentiation by using MRI-based 3D texture analysis.
Xiao DD; Yan PF; Wang YX; Osman MS; Zhao HY
Clin Neurol Neurosurg; 2018 Oct; 173():84-90. PubMed ID: 30092408
[TBL] [Abstract][Full Text] [Related]
15. Array-based profiling of the lymphoma cell DNA methylome does not unequivocally distinguish primary lymphomas of the central nervous system from non-CNS diffuse large B-cell lymphomas.
Vogt J; Wagener R; Montesinos-Rongen M; Ammerpohl O; Paulus W; Deckert M; Siebert R
Genes Chromosomes Cancer; 2019 Jan; 58(1):66-69. PubMed ID: 30284345
[TBL] [Abstract][Full Text] [Related]
16. LCK expression is a potential biomarker for distinguishing primary central nervous system lymphoma from glioblastoma multiforme.
Ge L; Xu L; Lu S; Yan H
FEBS Open Bio; 2020 May; 10(5):904-911. PubMed ID: 32237064
[TBL] [Abstract][Full Text] [Related]
17. Diagnostics and treatment delay in primary central nervous system lymphoma: What the neurosurgeon should know.
Hasner MC; van Opijnen MP; van der Meulen M; Verdijk RM; Maas SLN; Te Boome LCJ; Broekman MLD
Acta Neurochir (Wien); 2024 Jun; 166(1):261. PubMed ID: 38858236
[TBL] [Abstract][Full Text] [Related]
18. CSF neopterin level as a diagnostic marker in primary central nervous system lymphoma.
Viaccoz A; Ducray F; Tholance Y; Barcelos GK; Thomas-Maisonneuve L; Ghesquières H; Meyronet D; Quadrio I; Cartalat-Carel S; Louis-Tisserand G; Jouanneau E; Guyotat J; Honnorat J; Perret-Liaudet A
Neuro Oncol; 2015 Nov; 17(11):1497-503. PubMed ID: 26014047
[TBL] [Abstract][Full Text] [Related]
19. MR imaging based fractal analysis for differentiating primary CNS lymphoma and glioblastoma.
Liu S; Fan X; Zhang C; Wang Z; Li S; Wang Y; Qiu X; Jiang T
Eur Radiol; 2019 Mar; 29(3):1348-1354. PubMed ID: 30167811
[TBL] [Abstract][Full Text] [Related]
20. Surgery for primary central nervous system lymphoma: is it time for reevaluation?
Bierman PJ
Oncology (Williston Park); 2014 Jul; 28(7):632-7. PubMed ID: 25144286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
